The antihypertensive medicine market in Denmark is expected to grow from an actual sales value of 8.58 million USD PPP in 2023. Forecasts predict a gradual increase, with sales hitting 8.75 million USD PPP in 2024, 8.93 million USD PPP in 2025, 9.11 million USD PPP in 2026, 9.28 million USD PPP in 2027, and 9.45 million USD PPP in 2028.
Year-on-year percentage variations indicate a stable growth pattern:
- 2024: +1.98%
- 2025: +2.06%
- 2026: +2.01%
- 2027: +1.86%
- 2028: +1.83%
This shows an overall compound annual growth rate (CAGR) of approximately 1.95% from 2024 to 2028.
Future trends to watch:
- Potential impacts of new pharmaceutical innovations
- Changes in healthcare policies affecting medicine pricing
- Demographic shifts, notably the aging population
